The impact of resveratrol on the outcome of the in vitro fertilization: an exploratory randomized placebo-controlled trial

Table 2 Study protocol selection criteria

INCLUSION CRITERIA	EXCLUSION CRITERIA
Age ≥ 35 years	Presence of ovarian neoformations at the time of OS
AMH > 1.2 ng/ml [20]	Body Mass Index (BMI) < 18 and > 28 kg/m²
Regular menstrual cycle (every 25–35 days)	Polycystic ovary syndrome [21]
Indication for IVF/ICSI: idiopathic, tubal factor, mild and moderate male factor, maternal age	Endocrinopathies (disorders of the hypothalamic-pituitary axis, dysthyroidism or hyperprolactinaemia)
No previous ovarian surgery	Endometriosis III-IV Stage [22]
	Diabetes type I e II
	Severe male factor [23]

ISSN: 1757-2215